ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1244

Are Chinese-American Rheumatology Patients Who Use Traditional Chinese Medicine Less Adherent to Prescribed Western Medications?

Kai Sun1, Jackie Szymonifka2, Henghe Tian3, Ya Ju Chang4, Jennifer Leng5 and Lisa A. Mandl6, 1Hospital for Special Surgery/Weill Cornell medicine, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Internal Medicine, New York University School of Medicine, New York, NY, 4Mount Sinai Beth Israel, New York, NY, 5Immigrant Health and Cancer Disparities laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, 6Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Compliance, PROMIS and alternative medicine

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: High adherence is crucial for the management of rheumatic diseases. Nonadherence is more common among immigrants and minorities and may contribute to known outcome disparities. Chinese-American patients commonly use Traditional Chinese Medicine (TCM) and have worse outcomes in lupus and rheumatoid arthritis. Adherence among Chinese-American rheumatology patients has not been previously studied, and whether TCM use affects adherence to prescribed rheumatic disease medications is unknown.

Methods: Subjects were recruited from two rheumatology clinics that serve a predominantly Chinese-American immigrant population. Inclusion criteria were Chinese ethnicity, Mandarin or English fluency, and actively followed and prescribed ≥1 non-pro re nata (PRN), non-intravenous medication for a systemic rheumatic disease by rheumatologist. TCM use, adherence, Patient-Reported Outcomes Measurement Information System (PROMIS) domains, and other variables were assessed using validated instruments available in English and Chinese. Adherence was classified as high or medium/low based on the 8-item Morisky Medication Adherence Scale. Medication complexity was assessed using the Medication Regimen Complexity Index; higher score indicates more complexity. Chart review was performed to gather additional clinical data. Parametric and nonparametric statistics were performed as appropriate. Multivariable logistic regression using step-wise selection was used to assess factors independently associated with high adherence.

Results: 230 enrolled, median age 55 years (range 20-97), 65% female, 71% ≤ high school education, 70% Medicaid, and 22% reported English fluency. 50% reported TCM use in the past year, most frequently tuina massage (47%), acupuncture (45%), and herbs (37%). The three most common diagnoses were RA (41%), SLE (17%), and spondyloarthritis (15%), with median time since diagnosis of 4.1 years (range 0.2-52). High adherence to western medicine was found in 28.3%, while 37.4% and 34.4% had medium and low adherence. Both herb and non-herb TCM users had better rates of high adherence to western medicine compared to TCM nonusers (33% and 39% vs. 20% respectively, p=0.02). In multivariable analysis, high adherence was independently associated with TCM use (Odds Ratio [OR] 3.2, 95% confidence interval [CI] 1.6-6.7, p=0.002), older age (OR 1.1, 95% CI 1.03-1.1, p<0.001), unemployment (OR 4.1, 95% CI 1.5-11, p=0.005), married/living with partner (OR 2.3, 95% CI 1.2-5.9, p=0.02), more complex rheumatologic medication regimen (OR 1.1, 95% CI 1.02-1.2, p=0.02), and lower levels of anxiety (OR 0.9, 95% CI 1.02-1.1, p=0.001).

Conclusion: Among poorly integrated, low education, and low socioeconomic status Chinese-American rheumatology patients, high adherence rate was poor. TCM use was statistically significantly associated with high adherence to western medication. TCM use does not appear to represent an alternate but rather complementary approach to disease management. Future studies should evaluate whether TCM use is associated with disease activity and outcomes over time.


Disclosure: K. Sun, None; J. Szymonifka, None; H. Tian, None; Y. J. Chang, None; J. Leng, None; L. A. Mandl, Boehringer Ingelheim, 2,American College of Physicians, 3,Up To Date, 7.

To cite this abstract in AMA style:

Sun K, Szymonifka J, Tian H, Chang YJ, Leng J, Mandl LA. Are Chinese-American Rheumatology Patients Who Use Traditional Chinese Medicine Less Adherent to Prescribed Western Medications? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/are-chinese-american-rheumatology-patients-who-use-traditional-chinese-medicine-less-adherent-to-prescribed-western-medications/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-chinese-american-rheumatology-patients-who-use-traditional-chinese-medicine-less-adherent-to-prescribed-western-medications/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology